Abstract

Breakdown of the blood-brain barrier (BBB) is an early hallmark of multiple sclerosis (MS), a progressive inflammatory disease of the central nervous system. Cell adhesion in the BBB is modulated by sphingosine-1-phosphate (S1P), a signaling protein, via S1P receptors (S1P1). Fingolimod phosphate (FTY720-P) a functional S1P1 antagonist has been shown to improve the relapse rate in relapsing-remitting MS by preventing the egress of lymphocytes from lymph nodes. However, its role in modulating BBB permeability—in particular, on the tight junction proteins occludin, claudin 5 and ZO-1—has not been well elucidated to date. In the present study, FTY720-P did not change the transendothelial electrical resistance in a rat brain microvascular endothelial cell (RBMEC) culture exposed to inflammatory conditions and thus did not decrease endothelial barrier permeability. In contrast, occludin was reduced in RBMEC culture after adding FTY720-P. Additionally, FTY720-P did not alter the amount of endothelial matrix metalloproteinase (MMP)-9 and MMP-2 in RBMEC cultures. Taken together, our observations support the assumption that S1P1 plays a dual role in vascular permeability, depending on its ligand. Thus, S1P1 provides a mechanistic basis for FTY720-P-associated disruption of endothelial barriers—such as the blood-retinal barrier—which might result in macular edema.

Highlights

  • Multiple sclerosis (MS) is a progressive inflammatory disease of the central nervous system (CNS) [1]

  • The main effect of FTY720-P in MS is the alteration of lymphocyte trafficking via modulation of S1PT1h[e16m].aBirnaienffmecitcroofvFaTscYu7la2r0-ePndinotMheSliails ctehlelsa(lBteMraEtCiosn) roefplryesmenpthaocpyotesstibraleffiacdkdinitgionvaial tmarogdeut lfaotrion of FST1YP712[01-6P].inBMraSinpmatiiecnrotsvabsycudliarrecetnlydointtheerlfiearlincgellwsi(thBMthEeCfsu)nrcetipornesoefntthae pBoBsBs,ibsliencaedBdMitiEoCnaslatlasroget forexFpTrYes7s20S-1PP1in[1M7]S

  • Ipnataiefnirtsstbsyetdoirfecetxlpyeirnimteernfetrsi,ntgheweinthdoththeefluianl cptihoennootfytphiec BmBoBrp, hsionlcoegyBManEdCtshaelso expprreessesnSc1ePo1f a[1m7]o. noInlayaerfirwstassectonoffiremxepderbiympenhtass,e-tchoenternadstomthieclrioaslcopphyenaontdypimicmmuonropsthaoinloinggy oafntdhethe precesellns cwe iothf athme oenndoolatyheerliawl acselcl omnafirrkmeresdCbDy3p1haansde-vcoonntrWasiltlembricarnodscfoapctyoran(vdWimF)m(Fuinguorseta1in).inAgboouf tthe cel9l5s%wiotfhatlhleReBnMdoEtChselwiaelrceevllWmFa-rpkoesristivCeDi3n1diacnadtinvgona Whigilhledberagnrede foafctcoerll(cvuWltuFr)e(Fpiugruirtye.1T).hAe bboarurtie9r5% of faulnl RctBioMn EoCf sthwe eprreevseWntFc-pelolsciutilvtueriensdwicastinvegraifiheidghbydethgeredeeotefccteiollncuoflttuhree TpJu-prirtoyt.eTinhsecblaurrdieinr-f5uanncdtion of othccelupdreins.ent cell cultures was verified by the detection of the tight junction (TJ)-proteins claudin-5 and occludin

Read more

Summary

Introduction

Multiple sclerosis (MS) is a progressive inflammatory disease of the central nervous system (CNS) [1]. This disabling disease is characterized by multifocal demyelination, axonal loss, activation of glial cells, and infiltration by immune cells [1]. An early key event in the pathogenesis of MS is the loss of blood-brain barrier (BBB) integrity. Thereby, T helper lymphocytes secrete interleukin 17, which disrupts the BBB allowing efficient penetration of inflammatory cells into the brain [2]. The BBB consists of specialized brain endothelial cells which are supported in their barrier function by surrounding glial cells [4]. The function of the BBB is highly dependent on the expression and appropriate localization of tight junction (TJ) and adherens junction (AJ) complexes between

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call